Stille AB

Stockholm Stock Exchange STIL.ST

Stille AB Price to Earnings Ratio (P/E) on January 14, 2025: 65.15

Stille AB Price to Earnings Ratio (P/E) is 65.15 on January 14, 2025, a 32.78% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • Stille AB 52-week high Price to Earnings Ratio (P/E) is 77.76 on July 22, 2024, which is 19.37% above the current Price to Earnings Ratio (P/E).
  • Stille AB 52-week low Price to Earnings Ratio (P/E) is 46.79 on February 06, 2024, which is -28.18% below the current Price to Earnings Ratio (P/E).
  • Stille AB average Price to Earnings Ratio (P/E) for the last 52 weeks is 63.68.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
Stockholm Stock Exchange: STIL.ST

Stille AB

CEO Mr. Torbjorn Skold
IPO Date Nov. 29, 2005
Location Sweden
Headquarters Ekbacken 11
Employees 151
Sector Health Care
Industries
Description

Stille AB develops, manufactures, and sells surgical instruments in Sweden and internationally. It offers artery forceps and ligature clamps; bone cutters and rongeurs; clamps, curettes, raspatories, elevators, forceps, and micro instruments; needle holders, and wire twisting and holding forceps; and osteotomes, chisels, retractors and skin hooks, scissors, and other products, as well as c-arm tables. The company also provides ERCP/abdominal fluoroscopy, neuro/spine, pain management, urology, and vascular surgeries. In addition, it provides instrument repair, maintenance, and inspection services. Further, the company's products are used in various open surgeries. It has a collaboration agreement with GE Healthcare and distribution agreement with Synovis Micro. The company sells through OEM manufacturers of C-frames, distributors, and direct sales. The company was founded in 1841 and is headquartered in Torshälla, Sweden. Stille AB is a subsidiary of Linc AB.

Similar companies

CRAD-B.ST

C-Rad AB (publ)

USD 2.57

-0.02%

GENO.ST

Genovis AB (publ.)

USD 2.09

-2.04%

BOUL.ST

Boule Diagnostics AB (publ)

USD 0.89

14.73%

CEVI.ST

CellaVision AB (publ)

USD 18.76

3.89%

StockViz Staff

January 15, 2025

Any question? Send us an email